Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives Average Recommendation of “Buy” from Analysts
MarketBeatCorbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Get Free Report) has been assigned an average recommendation of “Buy” from the eight brokerages that are currently covering the company, Marketbeat reports. Seven investment analysts have rated the …